Melatonin’s Anti-Cancer Potential; Prenatal PFAS and Cancer; Anti-Viral Gel for HPV

Melatonin supplementation may help offset DNA damage associated with night-shift work. (Occupational & Environmental Medicine)

The government’s next list of drugs targeted for price negotiation could include the blockbuster immunotherapy pembrolizumab (Keytruda). (Endpoints News)

Despite losing hospital privileges in 2020 amid allegations of patient harm, a Montana oncologist’s license to practice was renewed by the state board of medical examiners in 2021, 2023, and now 2025. (ProPublica)

Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), so-called forever chemicals, in drinking water had “suggestive associations” with increased risk of childhood cancers. (University of California Irvine)

Progression-free survival improved significantly in hormone receptor-positive, ESR1-mutated breast cancer treated with the investigational oral selective estrogen receptor degrader camizestrant plus a CDK4/6 inhibitor, AstraZeneca announced.

A federal jury found a former Stanford University cancer research coordinator guilty of unlawfully accessing a clinical research database and altering patient data, according to the U.S. Attorney’s Office of the Northern District of California.

A first-of-its-kind antiviral gel may offer the potential to stop papillomavirus (HPV) infection before it causes cancer. (UNM Health Sciences)

Overall survival in certain patients with advanced gastroesophageal cancer improved significantly with the addition of the PD-L1 inhibitor sugemalimab to chemotherapy, CStone Pharmaceuticals announced.

Breast cancer survivors’ treatment-related decline in physical health persists long-term with chemotherapy but not endocrine therapy. (American Cancer Society)

Same mutation, different type of leukemia. How does that happen? (IRB Barcelona)

Please enable JavaScript to view the

comments powered by Disqus.